Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christopher D. Morgan is active.

Publication


Featured researches published by Christopher D. Morgan.


The Annals of Thoracic Surgery | 2002

Patient prosthesis mismatch is rare after aortic valve replacement: valve size may be irrelevant

Naoji Hanayama; George T. Christakis; Hari R. Mallidi; Campbell D. Joyner; Stephen E. Fremes; Christopher D. Morgan; Peter R.R Mitoff; Bernard S. Goldman

BACKGROUND Although small valve size and patient-prosthesis mismatch are both considered to decrease long-term survival, little direct evidence exists to support this hypothesis. METHODS To assess the prevalence of patient-prosthesis mismatch and the influence of small valve size on survival, we prospectively studied 1,129 consecutive patients undergoing aortic valve replacement between 1990 and 2000. Mean and peak gradients and indexed effective orifice area were measured by transthoracic echocardiography postoperatively (3 months to 10 years). Abnormal postoperative gradients were defined as those patients with mean or peak gradient above the 90th percentile (mean gradient > or = 21 or peak gradient > or = 38 mm Hg). Patient-prosthesis mismatch was defined as those patients with indexed effective orifice area below the 10th percentile (< 0.60 cm2/m2). RESULTS A multivariable analysis identified internal diameter of the implanted valve as the only independent predictor of abnormal gradients postoperatively. However, there was no significant difference in actuarial survival between normal and abnormal gradient groups (7 years: 91.2% +/- 1.5% versus 95.0% +/- 2.2%; p = 0.48). Freedom from New York Heart Association class III or IV (7 years: 74.5% +/- 3.1% versus 74.6% +/- 6.2%; p = 0.66) and left ventricular mass index were not different between normal and abnormal gradient groups. Patients with and without patient-prosthesis mismatch were similar with respect to postoperative left ventricular mass index, 7-year survival (95.1% +/- 1.3% versus 94.7% +/- 3.0%; p = 0.54), and 7-year freedom from New York Heart Association class III or IV (79.3% +/- 6.6% versus 74.5% +/- 2.5%; p = 0.40). In patients with patient-prosthesis mismatch and abnormal gradients, the majority had prosthesis dysfunction owing to degeneration. CONCLUSIONS Severe patient-prosthesis mismatch is rare after aortic valve replacement. Patient-prosthesis mismatch, abnormal gradient, and the size of valve implanted do not influence left ventricular mass index or intermediate-term survival.


Annals of Internal Medicine | 2006

Socioeconomic Status and Mortality after Acute Myocardial Infarction

David A. Alter; Alice Chong; Peter C. Austin; Cameron Mustard; Karey Iron; Jack I. Williams; Christopher D. Morgan; Jack V. Tu; Jane Irvine; C. David Naylor

Context Many studies show worse cardiovascular outcomes among poor persons than among affluent persons, but the factors that mediate this relationship are unknown. Contribution In this prospective study of 3407 Canadians who were hospitalized for myocardial infarction, 7.1% of the patients in the high-income group died within 2 years compared with 15.3% of the patients in the low-income group. Adjustment for age, preexisting cardiovascular disease, and risk factors greatly attenuated the relationship between mortality rates and income. Adjustment for other factors had little effect. Implications A history of 1 or more cardiovascular events and worse cardiovascular risk factors may explain why poor people have worse outcomes than affluent people after myocardial infarction. The Editors For many decades (1, 2) and across multiple nations (3-6), differences in socioeconomic status have been consistently associated with variations in cardiovascular disease and mortality rates (6, 7). This wealthhealth gradient (8) is independent of the socioeconomic indicator used (9), persists even after such cardiovascular events as acute myocardial infarction (MI) (10), and has been observed in countries with publicly funded universal health care (10-13). The causes of these incomeoutcome gradients are debatable (14-17). Poorer patients are more likely to smoke or have diabetes and hypertension, all of which lead to accelerated atherosclerosis and higher subsequent mortality rates (18, 19). However, incomeoutcome gradients persist after adjustment for cardiovascular events and traditional cardiac risk factors. These residual effects of income or education have led to speculation about differences in behaviors after MI, psychosocial stressors, and variations in access to medical care (10, 20-24). Although the mechanisms whereby psychosocial factors affect cardiovascular health are still incompletely delineated, ordinary risk factors (such as cigarette use) and health service intensity are potentially modifiable among the poor and those with less education. Therefore, our study focused on delineating the extent to which the association between socioeconomic factors and increased mortality rates can be explained by traditional risk factors and variations in service use. We hypothesized that cardiovascular risk factors remain the central intermediary pathway by which socioeconomic status is linked to increased mortality rates. We tested this hypothesis by using a cohort of patients who were hospitalized after an acute MI. By evaluating medium- term all-cause mortality in this sample, we increased the likelihood that death would be the result of a vascular event and reduced the risk for confounding by other causes of death (25). We aggregated traditional risk factors with previous vascular disease to obtain a powerful proxy for cumulative atherosclerotic burden, thereby enabling us to focus on assessing the incremental prognostic effect of socioeconomic status. Methods Data Source We obtained data from the Socio-Economic and Acute Myocardial Infarction (SESAMI) study, a prospective observational study of patients who were hospitalized because of acute MI throughout Ontario, Canada (19, 24). Of these data, we included a 13-item patient-completed questionnaire that addressed risk factors for atherosclerosis and socioeconomic status. By using encrypted health card numbers, we linked survey data to administrative databases for additional clinical information. We tracked each patients hospitalization history by using computerized abstracts that were assembled by the Canadian Institute for Health Information from 1 April 1988 to the date of the patients admission for the index event. We ascertained the number and types of cardiac procedures performed during and following the index admission by using the institutes data and physician billing claims from the Ontario Health Insurance Plan databases (10, 24). Procedure use reported in administrative databases was compared with patient self-reports; agreement levels ranged from 74% (coronary angiography) to 98% (coronary artery bypass surgery) and were similar across socioeconomic strata (24). We calculated patient deaths by acquiring data from the Ontario Registered Persons Data Base. Study Sample The SESAMI investigators recruited English-speaking patients who were admitted through the emergency departments in 53 of 57 large-volume (defined as having 100 or more patient admissions for MI per year) Ontario hospitals between 1 December 1999 and 26 February 2003. Trained nurses identified eligible patients through chart surveillance while patients were hospitalized in coronary or intensive care units. The diagnosis of MI was confirmed if at least 2 of 3 criteria were met: presence of symptoms, abnormal electrocardiographic findings, or elevated serum levels of cardiac enzymes. Of all eligible patients, 96% had acute MI confirmed by chart audits (19). We excluded patients younger than 19 years of age or older than 101 years of age, those lacking a valid health card number issued by the province of Ontario, and those who were transferred to the recruiting hospital. To be eligible, patients were required to complete a self-administered baseline survey at study entry. This requirement rendered ineligible those dying within 24 hours, those who had very severe illness (for example, patients receiving mechanical ventilation), those who had language barriers, or those undergoing early discharge or transfer (19, 24). Among 4668 consecutive eligible patients approached for consent, 3504 agreed to participate in baseline surveys and subsequent data linkage. For purposes of this study, 97 patients could not be linked to administrative data because of invalid or inaccurately documented health card numbers; 3407 patients remained available for participation. Socioeconomic Status, Ethnicity, and Demographic Factors We assessed self-reported household annual income (from all sources) as a 7-level categorical variable ranging from less than


The Annals of Thoracic Surgery | 2002

Are stentless valves hemodynamically superior to stented valves? A prospective randomized trial

Gideon Cohen; George T. Christakis; Campbell D. Joyner; Christopher D. Morgan; Miguel Tamariz; Naoji Hanayama; Hari R. Mallidi; John P. Szalai; Marko Katic; Vivek Rao; Stephen E. Fremes; Bernard S. Goldman

15000 to greater than


American Journal of Cardiology | 1987

Medical management of malignant pericardial effusion by tetracycline sclerosis

Frances A. Shepherd; Christopher D. Morgan; William K. Evans; Jeffrey F. Ginsberg; David Watt; Kevin Murphy

80000 Canadian. Self-reported educational attainment was analyzed as a 5-level categorical variable ranging from an incomplete high school education to a university degree. Income and education levels were self-reported by 92% and 98% of participants, respectively. To mitigate the confounding effect of retirement from the labor force, the cohort was stratified into persons younger than 65 years of age and those 65 years of age and older (12, 26). To ensure similar sample sizes across socioeconomic subgroups, we reaggregated income categories into a 3-level ordinal variable for each age group. For the younger age group, income categories were less than


Journal of the American College of Cardiology | 1989

Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction

Paul W. Armstrong; Ronald S. Baigrie; Paul A. Daly; Aminul Haq; Michael Gent; Robin S. Roberts; Michael R. Freeman; Robert J. Burns; Peter Liu; Christopher D. Morgan

30000,


The Annals of Thoracic Surgery | 1996

Left Ventricular Mass Regression Early After Aortic Valve Replacement

George T. Christakis; Campbell D. Joyner; Christopher D. Morgan; Stephen E. Fremes; Karen J. Buth; Jeri Sever; Vivek Rao; Kostas P. Panagiotopoulos; Patricia M. Murphy; Bernard S. Goldman

30000 to


Circulation | 1992

Thrombolysis in unstable angina: Randomized double-blind trial of t-PA and placebo

Michael R. Freeman; Anatoly Langer; Robert F. Wilson; Christopher D. Morgan; Paul W. Armstrong

59999, and at least


Journal of the American College of Cardiology | 1992

Pathophysiology and prognostic significance of holter-detected ST segment depression after myocardial infarction☆

Anatoly Langer; Joseph Minkowitz; Paul Dorian; Luigi Casella; Louise Harris; Christopher D. Morgan; Paul W. Armstrong

60000 Canadian; for the older age group, the categories were less than


Journal of Cardiac Surgery | 2005

Determinants of Incomplete Left Ventricular Mass Regression Following Aortic Valve Replacement for Aortic Stenosis

Naoji Hanayama; George T. Christakis; Hari R. Mallidi; Vivek Rao; Gideon Cohen; Bernard S. Goldman; Stephen E. Fremes; Christopher D. Morgan; Campbell D. Joyner

20000,


Journal of the American College of Cardiology | 1991

Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial

Christopher D. Morgan; Robin S. Roberts; Aminul Haq; Ronald S. Baigrie; Paul A. Daly; Michael Gent; Paul W. Armstrong

20000 to

Collaboration


Dive into the Christopher D. Morgan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

George T. Christakis

Sunnybrook Health Sciences Centre

View shared research outputs
Top Co-Authors

Avatar

Stephen E. Fremes

Sunnybrook Health Sciences Centre

View shared research outputs
Top Co-Authors

Avatar

Campbell D. Joyner

Sunnybrook Health Sciences Centre

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gideon Cohen

Sunnybrook Health Sciences Centre

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hari R. Mallidi

Brigham and Women's Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge